COMMUNIQUÉS West-GlobeNewswire

-
Vaxil Granted Significant US Patent for Anti-Infective Vaccines
21/05/2019 -
BioSyent Schedules Q1 2019 Earnings Release for May 29, 2019
21/05/2019 -
Matinas BioPharma Announces Abstract Accepted for Presentation at ASM Microbe 2019
21/05/2019 -
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
21/05/2019 -
Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant
21/05/2019 -
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Products Receives Great Response -- Company in Discussion with Wholesalers for Mass Distribution of ProMED CBD Product Lines for an Initial 500 Outlets Nationally
21/05/2019 -
Progressive Care Inc. Announces April Sales & Record Breaking Month
21/05/2019 -
Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
21/05/2019 -
Protech Home Medical Reports Solid Second Quarter Fiscal 2019 Financial Results
21/05/2019 -
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
21/05/2019 -
PSIQ Reports Record Breaking Revenue Increase of Almost 120% for Its Hemp Derived CBD Product Line
21/05/2019 -
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
21/05/2019 -
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
21/05/2019 -
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)
21/05/2019 -
Emerald Health Therapeutics tiendra une conférence téléphonique sur ses résultats financiers du premier trimestre 2019 le 31 mai prochain
21/05/2019 -
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
21/05/2019 -
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
21/05/2019 -
Crinetics Pharmaceuticals Initiates Phase 1 Study of CRN01941 for the Treatment of Neuroendocrine Tumors
21/05/2019 -
Emerald Health Therapeutics to Hold Conference Call on First Quarter 2019 Financial Results on May 31st
21/05/2019
Pages